Phase
Condition
Kidney Failure
Treatment
N/AClinical Study ID
Ages 18-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria (Patients with ADPKD):
Male and female subjects 18 - 40 years of age, inclusive
Previous diagnosis of ADPKD (based on Ravine et al. criteria)
Class 1 according to imaging classification
Estimated GFR> 90 mL/min/m2 (CKD-Epi equation)
Ability to provide written, informed consent
Inclusion Criteria (Healthy Volunteers):
Male and female subjects 18 - 40 years of age, inclusive
Estimated GFR> 90 mL/min/m2 (CKD-Epi equation)
Ability to provide written, informed consent
Exclusion Criteria (Patients with ADPKD):
Class 2 according to imaging classification
A concomitant systemic disease affecting the kidney (e.g., lupus, hepatitis B or C, amyloidosis)
Diabetes mellitus (fasting glucose > 126 mg/dL or treatment with insulin or oral hypoglycemics).
Predicted urine protein excretion in urinalysis >1 g/24 hrs.
Subjects having contraindications to or interference with MRI assessments. [For example ferromagnetic metal prostheses, aneurysm clips, severe claustrophobia, large abdominal/back tattoos, etc.].
History of hypersensitivity allergic reactions to ultrasound contrast agents
High-risk cardiac disease (such as unstable hospital in-patients or ICU patients
Patients that are part of an interventional study or are taking tolvaptan
Female subjects that are pregnant
Exclusion Criteria (Healthy Volunteers):
Family and/or personal history of kidney disease
Concomitant systemic disease that may affect the kidney
Diabetes mellitus
Predicted urine protein excretion in >1 g/24 hrs, and or Abnormal urinalysis
Pregnant or lactating women
Subjects having contraindications to or interference with MRI assessments. [For example ferromagnetic metal prostheses, aneurysm clips, severe claustrophobia, large abdominal/back tattoos, etc.].
History of hypersensitivity allergic reactions to ultrasound contrast agents
High risk cardiac disease (such as unstable hospital in-patients or ICU patients
Study Design
Study Description
Connect with a study center
Mayo Clinic
Rochester, Minnesota 55905
United StatesSite Not Available
Mayo Clinic
Rochester 5043473, Minnesota 5037779 55905
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.